News >

Work Remains With Immunotherapy in Ovarian Cancer

Caroline Seymour
Published: Friday, May 31, 2019

Daphne B. Stewart, MD

Daphne B. Stewart, MD

Although the utility of immunotherapy is limited to a small percentage of patients with advanced epithelial ovarian cancer, research continues to define these responders in the hopes of providing them with durable responses and potential remissions, explained Daphne B. Stewart, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication